Sun Pharmaceuticals
Sun Pharma, Ranbaxy to merge in Rs24,000 all-stock deal
07 Apr 2014
The merger will create India's largest pharmaceutical company and the world's fifth largest speciality generics company with annual emerging market sales nearing Rs6,000 crore
And now, USFDA bans imports from Sun Pharma unit
13 Mar 2014
The US regulator has been cracking down heavily on Indian generic pharmaceutical firms such as Ranbaxy and Wockhardt for alleged failure to comply with its manufacturing norms
Teva, Sun Pharma to pay Pfizer $2.15 bn to settle patent suit
12 Jun 2013
Teva, the world’s largest generic drug firm, will pay $1.6 billion of the settlement amount while Sun Pharmaceuticals will pay the remaining $550 million
Sun Pharma in discussion to acquire controlling stake in Meda AB
31 May 2013
Sun Pharmaceutical Industries is in discussions to acquire a controlling stake in Swedish drugmaker Meda AB for around $5 billion to boost its generics business in developed markets
Sun Pharma calls off $600-million buyout of Taro
08 Feb 2013
Sun Pharma's latest buyout offer of $39.50 per share for 15 million scrips was 61 per cent higher than its previous offer of $24.50, which Taro had rejected
